Head and Neck Cancer Trial, Recruiting (NCT06905145)

Head and Neck Cancer Trial, Recruiting NCT06905145 Sponsor: National Cancer Institute, Naples Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06905145 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 18 years of age
People who are able to provide written consent to participate, as approved by an ethics committee
People who have been diagnosed through a tissue test with squamous cell carcinoma (a type of cancer) located in the head and neck area, specifically in the mouth, throat (oropharynx), voice box (larynx), or lower throat (hypopharynx)
People whose cancer is at a locally advanced stage, meaning it has not spread to distant parts of the body but may have spread to nearby lymph nodes (stages ranging from T1N1M0 to T4N3M0 — confirm with trial site if unsure what stage applies)
People for whom a tissue sample from a biopsy taken as part of standard clinical care is available

Who may not be able to join:

People whose cancer has come back after previous treatment or has spread to distant parts of the body
People who have a second, separate cancer diagnosed at the same time as their head and neck cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francesco Perri, MD, IRCCS I.N.T. "G. Pascale"

Phone: 08117770403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06905145

Sponsor: National Cancer Institute, Naples

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 08117770403

More information: https://clinicaltrials.gov/study/NCT06905145

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 18 years of age
People who are able to provide written consent to participate, as approved by an ethics committee
People who have been diagnosed through a tissue test with squamous cell carcinoma (a type of cancer) located in the head and neck area, specifically in the mouth, throat (oropharynx), voice box (larynx), or lower throat (hypopharynx)
People whose cancer is at a locally advanced stage, meaning it has not spread to distant parts of the body but may have spread to nearby lymph nodes (stages ranging from T1N1M0 to T4N3M0 — confirm with trial site if unsure what stage applies)
People for whom a tissue sample from a biopsy taken as part of standard clinical care is available

Who may not be able to join:

People whose cancer has come back after previous treatment or has spread to distant parts of the body
People who have a second, separate cancer diagnosed at the same time as their head and neck cancer

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute, Naples

Registry

ClinicalTrials.gov

Start date

3 May 2024

Est. completion

1 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Percentage of P53 Expression in Tumor Tissue in Groups A and B

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov